Impact of IFN-Free and IFN-Based Treatment on Blood Myeloid Dendritic Cell, Monocyte, Slan-DC, and Activated T Lymphocyte Dynamics during HCV Infection

被引:2
|
作者
Vita, Serena [1 ,2 ]
Zuccal, Paola [1 ]
Savinelli, Stefano [1 ]
Mascia, Claudia [1 ]
Rossi, Raffaella [1 ]
Schiavone, Francesco [3 ]
Marocco, Raffaella [2 ]
Tieghi, Tiziana [2 ]
Iannetta, Marco [1 ]
Nijhawan, Parni [1 ]
Zingaropoli, Maria Antonella [1 ]
d'Ettore, Gabriella [1 ]
Vullo, Vincenzo [1 ]
Mastroianni, Claudio Maria [1 ]
Lichtner, Miriam [1 ]
机构
[1] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Rome, Italy
[2] SM Goretti Hosp, Latina, Italy
[3] Sapienza Univ Rome, Dept Mol Med, Rome, Italy
关键词
HEPATITIS-C; GENOTYPE; IMMUNE-RESPONSES; TRIPLE THERAPY; LIVER FIBROSIS; INTERFERON; BOCEPREVIR; TELAPREVIR; RIBAVIRIN; INNATE;
D O I
10.1155/2020/2781350
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Chronic hepatitis C virus infection leads to the activation of innate immunity, a key component in HCV fibrosis. In the past, the use of IFN-based treatment regimens did not permit an adequate evaluation of the impact of HCV clearance on immune cells, because of their antiviral and immunomodulatory properties. The recent development of direct-acting antiviral (DAA) therapy, which is associated with high rates of sustained virological response, enables a more accurate analysis of the immunological modifications following HCV eradication. We studied the dynamics of blood myeloid dendritic cells, monocytes, slan-DCs, and T lymphocytes during IFN-free and IFN-based regimens in hepatitis C virus infection.
引用
收藏
页数:11
相关论文
共 1 条
  • [1] Quality of Life for HCV-infected Patients during Treatment: Are IFN-free Better than IFN-based Regimens?
    Nickerson, Jillian
    Bichoupan, Kian
    Harty, Alyson
    Weiss, Jeffrey J.
    Perumalswami, Ponni
    Schiano, Thomas D.
    Dieterich, Douglas
    Branch, Andrea D.
    HEPATOLOGY, 2014, 60 : 693A - 693A